MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment

CompletedOBSERVATIONAL
Enrollment

1,342

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

April 30, 2009

Conditions
Prostatic Hyperplasia
Trial Locations (18)

Unknown

Boehringer Ingelheim Investigational Site, Barranquilla

Boehringer Ingelheim Investigational Site, Bogotá

Boehringer Ingelheim Investigational Site, Boyacá

Boehringer Ingelheim Investigational Site, Bucaramanga

Boehringer Ingelheim Investigational Site, Cartagena

Boehringer Ingelheim Investigational Site, Cúcuta

Boehringer Ingelheim Investigational Site, Ibagué

Boehringer Ingelheim Investigational Site, Manizales

Boehringer Ingelheim Investigational Site, Medellín

Boehringer Ingelheim Investigational Site, Palmira

Boehringer Ingelheim Investigational Site, Pereira

Boehringer Ingelheim Investigational Site, Popayán

Boehringer Ingelheim Investigational Site, Santa Marta

Boehringer Ingelheim Investigational Site, Santiago de Cali

Boehringer Ingelheim Investigational Site, Sincelejo

Boehringer Ingelheim Investigational Site, Tuluá

Boehringer Ingelheim Investigational Site, Valledupar

Boehringer Ingelheim Investigational Site, Villavicencio

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00885027 - MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment | Biotech Hunter | Biotech Hunter